CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 60724 | LVS EN ISO 10993-16:2018 | Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2017) | Standarts spēkā |
| 38319 | LVS EN ISO 10993-6:2017 | Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO 10993-6:2016) | Standarts spēkā |
| 9493 | LVS EN ISO 10993-7:2009 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008) | Standarts spēkā |
| 60133 | EN ISO 10993-11:2018 | Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017) | Standarts spēkā |
| 79539 | EN ISO 14155:2020/A11:2024 | Clinical investigation of medical devices for human subjects - Good clinical practice | Standarts spēkā |
| 78988 | prEN ISO 10993-3 | Biological evaluation of medical devices - Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity, and developmental toxicity (ISO/DIS 10993-3:2025) | Aptauja slēgta |
| 77933 | prEN ISO 10993-11 | Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO/DIS 10993-11:2025) | Aptauja slēgta |
| 9489 | LVS EN ISO 10993-15:2003 | Biological evaluation of medical devices - Part 15: Identification and quantification of degradation products from metals and alloys | Atcelts |
| 9499 | EN ISO 10993-17:2002 | Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances (ISO 10993-17:2002) | Atcelts |
| 27092 | LVS EN ISO 10993-1:2010 | Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2009) | Atcelts |
Displaying 51-60 of 190 results.